Skip to main content
. 2019 Jan 2;10(3):331–338. doi: 10.3892/mco.2019.1795

Figure 2.

Figure 2.

Expression of NUCKS1 in GBMs (GBM1-3) and GBM cell lines (A172, U87MG and resistant-T98G cells). *P<0.05 in the T98G vs. the GBM1, GBM2, GBM3, U87MG and A172 cell lines. GBM, glioblastoma multiforme; NUCKS1, nuclear casein kinase and cyclin dependent kinase substrate 1; POOL, non-tumoral pool group.